Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Development of nomogram based on immune-related gene FGFR4 for advanced non-small cell lung cancer patients with sensitivity to immune checkpoint inhibitors

Fig. 4

Novel nomogram to predict the prognosis of advanced NSCLC with ICIs treatment. a The survival curves for ICIs treatment based on the mutational status of FGFR4; b the survival curves for ICIs treatment based on the pathology; c the survival curves for ICIs treatment based on treatment line; d the survival curves for ICIs treatment based on the smoking; e the survival curves for ICIs treatment based on PD-L1 expression; f the survival curves for ICIs treatment based on TMB; g the novel nomogram based on these clinical information to predict the prognosis of ICI treatment; h the calibration plot for the 6 month PFS of nomogram; i the calibration plot for the 12 month PFS of nomogram

Back to article page